Bionano to Present at the RBC Capital Markets 2024 Global He

SAN DIEGO, April 30, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (NASDAQ:BNGO) today announced that Erik Holmlin, PhD, Bionano's president and chief executive officer, will present at the RBC Capital Markets 2024

Related Keywords

David Holmes , Erik Holmlin , Lineagen Inc , Bionano Genomics Inc , Company Contact , Gilmartin Group , Healthcare Conference , Bionano Laboratories ,